-
UTI Healthcare Fund Regular Plan Growth
Equity healthcare
Overview ( as on 30/05/25 )
NAV
₹276.61
Last change
₹-0.74 -0.0%
Fund Size (AUM)
1037.49 Cr
Performance
21.83% (5Y)
Fund Details
UTI Healthcare Fund Regular Plan Growth
as of 30/05/25
AUM
1037.49 Cr
Expense Ratio
2.25 %
Benchmark
BSE Healthcare TR INR
ISIN
INF789F01695
Fund Manager
Kamal Gada
Exit Load
1.0% if redeemed within 0-30 days
0% if redeemed after 30 days
| Fund Performance | 1Y | 3Y | 5Y |
|---|---|---|---|
| UTI Healthcare Fund Regular Plan Growth | 23.2% | 24.08% | 21.83% |
| BSE Healthcare TR INR | 22.11% | 23.78% | 22.18% |
Top 10 Holdings
Sun Pharmaceuticals Industries Ltd |
11.88% |
Cipla Ltd |
5.98% |
Dr Reddy's Laboratories Ltd |
4.52% |
Ajanta Pharma Ltd |
4.51% |
Procter & Gamble Health Ltd |
3.91% |
Apollo Hospitals Enterprise Ltd |
3.78% |
Glenmark Pharmaceuticals Ltd |
3.66% |
Divi's Laboratories Ltd |
3.29% |
Alkem Laboratories Ltd |
3.15% |
Fortis Healthcare Ltd |
3.07% |
Sector Allocation
Healthcare |
99.02% |
Basic Materials |
0.98% |
Asset Allocation
-
99%
Equity
-
1%
Others
-
0%
Debt
Risk and Return Category
Risk v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Return v/s Category
-
Low
-
Below Average
-
Average
-
Above Average
-
High
Related Funds
-
ICICI Pru Pharma Healthcare Diag Gr
Equity healthcare-
Returns
-
25.6% (5Y)
-
-
ICICI Pru Pharma Healthcare Dg IDCW-R
Equity healthcare-
Returns
-
22.82% (5Y)
-
-
SBI Healthcare Opportunities Reg Gr
Equity healthcare-
Returns
-
24.14% (5Y)
-
-
SBI Healthcare Opportunities Reg IDCW-R
Equity healthcare-
Returns
-
24.14% (5Y)
-
-
UTI Healthcare Reg Gr
Equity healthcare-
Returns
-
21.83% (5Y)
-
-
UTI Healthcare Reg IDCW-P
Equity healthcare-
Returns
-
21.83% (5Y)
-
